IRWD FY 2016 Earnings — Ironwood Pharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena

IRWDIronwood Pharmaceuticals, Inc.

$603M

FY 2016 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$274M+83.2% YoY

Gross Profit

$272M99.3% margin

Operating Income

-$52M-18.9% margin

Net Income

-$82M-29.8% margin

EPS (Diluted)

$-0.56

Cash Flow

Operating Cash Flow

-$25M

Free Cash Flow

-$130M

Stock-Based Comp.

$29M

Balance Sheet

Total Assets

$710M

Total Liabilities

$643M

Stockholders' Equity

$67M

Cash & Equivalents

$54M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$274M	$150M	+83.2%
Gross Profit	$272M	$150M	+81.9%
Operating Income	-$52M	-$102M	+49.2%
Net Income	-$82M	-$143M	+42.7%